Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 21;83(11):1597-1598.
doi: 10.1136/ard-2024-226017.

Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis

Aiden Haghikia #  1 , Tobias Hegelmaier #  2 , Denise Wolleschak  3 , Martin Böttcher  3   4 , Vaia Pappa  2 , Jeremias Motte  5 , Dominic Borie  6 , Ralf Gold  5 , Eugen Feist  7 , Georg Schett #  8   9 , Dimitrios Mougiakakos #  10   4
Affiliations

Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis

Aiden Haghikia et al. Ann Rheum Dis. .
No abstract available

Keywords: Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoimmune Diseases; Autoimmunity; B-Lymphocytes.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AH has served on scientific advisory boards for Galapagos, Novartis and Merck Serono; received speaker honoraria from Biogen Idec, Merck Serono and Novartis; and received limited research grants from Merck Serono. DB is an employee and shareholder of Kyverna Therapeutics. EF has received speaker honoraria from AbbVie, BMS, Galapagos, Janssen, Lilly, Novartis, Roche, Sanofi and Pfizer. GS has received speaker honoraria from BMS, Cabaletta, Janssen, Kyverna, Miltenyi and Novartis. DM has received speaker honoraria and consulting fees from Abbvie, BMS, Beigene, Celgene, Galapagos, Gilead, Janssen, Miltenyi and Novartis.

LinkOut - more resources